Nanocarriers Usage for Drug Delivery in Cancer Therapy

Nanocarriers Usage for Drug Delivery in Cancer Therapy Publisher

Khodabandehloo H¹ ; Zahednasab H² ; Hafez AA³

Source: International Journal of Cancer Management Published:2016

Abstract

Conventional therapeutic agents have displayed significant shortcomings. For this reason, important achievements have effectively made in biotechnology for delivering the therapeutic agents to the site of action, and diminish side effects. Polymeric carriers, micelles, dendrimers, liposomes, solid lipid carriers, gold carriers, viral carriers, nanotubes and magnetic carriers incorporating cytotoxic therapeutics have developed. To improve biological distribution of therapeutic drugs, some modified carriers have designed in optimal size and modified surface area. Delivery of carriers to target cells could be done by passive and active targeting. © 2016, Iranian Journal of Cancer Prevention.

Related Docs

View other Related Docs

1. The Use of Nanoparticles As a Promising Therapeutic Approach in Cancer Immunotherapy, Artificial Cells# Nanomedicine and Biotechnology (2016)

2. Optimizing Cancer Treatment: A Comprehensive Review of Active and Passive Drug Delivery Strategies, Iranian Biomedical Journal (2025)

3. Antibody-Drug Therapeutic Conjugates: Potential of Antibody-Sirnas in Cancer Therapy, Journal of Cellular Physiology (2019)

Experts (# of related papers)

View all Related Experts

Fatemeh Atyabi (1)

Seyed Mahdi Rezayat Sorkhabadi (1)

Style	Citing Format
MLA	Khodabandehloo H, Zahednasab H, Hafez AA. "Nanocarriers Usage for Drug Delivery in Cancer Therapy." International Journal of Cancer Management, vol. 9, no. 2, 2016, pp. -.
APA	Khodabandehloo H, Zahednasab H, Hafez AA (2016). Nanocarriers Usage for Drug Delivery in Cancer Therapy. International Journal of Cancer Management, 9(2), -.
Chicago	Khodabandehloo H, Zahednasab H, Hafez AA. "Nanocarriers Usage for Drug Delivery in Cancer Therapy." International Journal of Cancer Management 9, no. 2 (2016): -.
Harvard	Khodabandehloo H, Zahednasab H, Hafez AA (2016) 'Nanocarriers Usage for Drug Delivery in Cancer Therapy', International Journal of Cancer Management, 9(2), pp. -.
Vancouver	Khodabandehloo H, Zahednasab H, Hafez AA. Nanocarriers Usage for Drug Delivery in Cancer Therapy. International Journal of Cancer Management. 2016;9(2):-.
BibTex	@article{ author = {Khodabandehloo H and Zahednasab H and Hafez AA}, title = {Nanocarriers Usage for Drug Delivery in Cancer Therapy}, journal = {International Journal of Cancer Management}, volume = {9}, number = {2}, pages = {-}, year = {2016} }
RIS	TY - JOUR AU - Khodabandehloo H AU - Zahednasab H AU - Hafez AA TI - Nanocarriers Usage for Drug Delivery in Cancer Therapy JO - International Journal of Cancer Management VL - 9 IS - 2 SP - EP - PY - 2016 ER -

Science Communicator Platform

Authors

Abstract